![]() |
||||
|
||||
|
|
||||
Re: HRT and choleithiasisFrom: Terrence.Jones@ncal.kaiperm.orgTue Oct 29 00:13:56 1996
Joe, thought I'd add my 2 gms of lard, or crisco, of other fast-food derivative... Had a pt. with recurrent biliary duct stone post-chole, removed endoscopically, along with ampullary dilation. She wanted to continue PERT (HRT) and her GI Doc said it would be OK considering she had ampullary dilation. The Pt had questions regarding lithogenic tendencies of oral Vs transdermal. Found a article by Van Erpecum from 1991, (Gastroent. 4/91, vol 100:482-88). The numbers were small (17 pts) and demonstrated the usual rise in E1 (estrone), associated with oral estradiol compared to trans- dermal (secondary to first pass hepatic metabolic fx). However, there was a subgroup in which the rise was much higher (E1 more than 0.5 pmol/ml, n=8). These pts had an increased biliary saturation index on oral estradiol that was not evident on transdermal. Anyone have any experience with estrogen and pts with CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalo- pathy)? (Weller, Neurology 3/96, 46:844). Terry.
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 05:17:30 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.